Sastasundar Ven.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE019J01013
  • NSEID: SASTASUNDR
  • BSEID: 533259
INR
293.15
2.1 (0.72%)
BSENSE

Feb 13

BSE+NSE Vol: 6.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

6.48 k (-43.14%) Volume

Shareholding (Dec 2025)

FII

2.25%

Held by 5 FIIs

DII

2.07%

Held by 0 DIIs

Promoter

74.69%

Who are the top shareholders of the Sastasundar Ven.?

06-Jun-2025

The top shareholder of Sastasundar Ven. is Banwari Lal Mittal, holding 33.37%. Other shareholders include four foreign institutional investors with 1.6%, individual investors at 13.7%, and the highest public shareholder, Lekh Raj Juneja, with 1.89%.

The top shareholders of Sastasundar Ven. include the promoters, with Banwari Lal Mittal holding the highest stake at 33.37%. There are no pledged promoter holdings. In terms of institutional investors, the company is held by four foreign institutional investors (FIIs) with a combined holding of 1.6%. Additionally, individual investors collectively own about 13.7% of the shares, while the highest public shareholder is Lekh Raj Juneja, who holds 1.89%. Mutual funds currently hold shares through two schemes, but their stake is negligible at 0.0%.

View full answer

how big is Sastasundar Ven.?

06-Jun-2025

As of Jun 06, Sastasundar Ventures Ltd has a market capitalization of 878.45 Cr and reported net sales of 1110.95 Cr with a net profit of -91.53 Cr over the latest four quarters. Shareholder's funds are 762.37 Cr, and total assets amount to 1,149.19 Cr as of Mar'24.

Market Cap: As of Jun 06, Sastasundar Ventures Ltd has a market capitalization of 878.45 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which includes data from Mar'25, Dec'24, Sep'24, and Jun'24, is 1110.95 Cr. The sum of Net Profit for the same quarters is -91.53 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending Mar'24. The Shareholder's Funds are reported at 762.37 Cr, and the Total Assets amount to 1,149.19 Cr.

View full answer

Who are in the management team of Sastasundar Ven.?

06-Jun-2025

As of March 2022, the management team of Sastasundar Ven. includes Banwari Lal Mittal (Chairman & Managing Director), Ravi Kant Sharma, Abha Mittal, Parimal Kumar Chattaraj, Rupanjana De, J. N. Mukhopadhyaya (all Directors), Pratap Singh (Company Secretary), and Anjana Dikshit (Additional Director). Each member contributes to the company's governance and strategic direction.

As of March 2022, the management team of Sastasundar Ven. includes the following individuals:<BR><BR>1. Banwari Lal Mittal - Chairman & Managing Director<BR>2. Ravi Kant Sharma - Director<BR>3. Parimal Kumar Chattaraj - Independent Director<BR>4. Abha Mittal - Director<BR>5. Rupanjana De - Independent Director<BR>6. Pratap Singh - Company Secretary & Compliance Officer<BR>7. J. N. Mukhopadhyaya - Independent Director<BR>8. Anjana Dikshit - Additional Director<BR><BR>Each member plays a vital role in the governance and strategic direction of the company.

View full answer

Has Sastasundar Ven. declared dividend?

06-Jun-2025

Sastasundar Ventures Ltd has declared a 10% dividend, amounting to ₹1 per share, with an ex-date of July 23, 2012. However, the dividend yield is 0%, and total returns have varied, showing significant gains over the 5-year period despite negative returns in shorter terms.

Sastasundar Ventures Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 23 Jul 12<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -23.17%, the dividend return was 0%, resulting in a total return of -23.17%.<BR><BR>In the 1-year period, the price return was -10.7%, the dividend return was 0%, leading to a total return of -10.7%.<BR><BR>Over the 2-year period, the price return was -6.26%, the dividend return was 0%, which resulted in a total return of -6.26%.<BR><BR>In the 3-year period, the price return was -13.84%, the dividend return was 0%, culminating in a total return of -13.84%.<BR><BR>For the 4-year period, the price return was 20.91%, the dividend return was 0%, giving a total return of 20.91%.<BR><BR>In the 5-year period, the price return was 227.56%, the dividend return was 0%, resulting in a total return of 227.56%.<BR><BR>Overall, while Sastasundar Ventures Ltd declared a dividend, the dividend yield remains at 0%, indicating no additional income from dividends in recent periods. The total returns show a mixed performance, with significant gains over the long term, particularly in the 5-year period, despite negative returns in the shorter terms.

View full answer

Who are the peers of the Sastasundar Ven.?

03-Jun-2025

Sastasundar Ven.'s peers include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Prevest Denpro, Nureca, Bilcare, and One Global Serv. One Global Serv leads in 1-year returns at 159.28%, while Sastasundar Ven. has a -14.32% return.

Peers: The peers of Sastasundar Ven. are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Prevest Denpro, Nureca, Bilcare, and One Global Serv.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs and One Global Serv, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, and Vijaya Diagnost., and the rest have Average or Below Average ratings. Growth is Excellent for One Global Serv, Average for Sastasundar Ven., Poly Medicure, Indegene, and Nureca, while Below Average growth is noted for Syngene Intl., Dr Lal Pathlabs, Vijaya Diagnost., Prevest Denpro, and Bilcare. In terms of Capital Structure, Excellent ratings are given to Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Sastasundar Ven., Prevest Denpro, Nureca, and One Global Serv, while Bilcare has a Below Average rating.<BR><BR>Return Snapshot: One Global Serv has the highest 1-year return at 159.28%, while Sastasundar Ven. has a 1-year return of -14.32%, which is significantly lower than the highest peer. Additionally, Syngene Intl., Vijaya Diagnost., and Bilcare have negative six-month returns.

View full answer

What does Sastasundar Ven. do?

17-Jul-2025

Sastasundar Ventures Ltd is a micro-cap company in the healthcare services industry, reporting net sales of ₹2,858 Cr and a net profit of ₹137 Cr for March 2025. It has a market cap of ₹937 Cr, a P/E ratio of 9.00, and a return on equity of 14.79%.

Overview:<BR>Sastasundar Ventures Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 1989 as 'Satyam Fiscal Services Private Limited' and underwent several name changes, becoming 'Microsec Financial Services Limited' in 2005 after converting to a public limited company. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2,858 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 137 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 937 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 9.00 <BR>Industry P/E: 23 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 14.79% <BR>Price to Book: 1.36<BR><BR>Contact Details:<BR>Address: Azimganj House 2nd Floor, 7 Abanindra Nath Thakur Sarani Kolkata West Bengal : 700017 <BR>Tel: 91-33-22829330 <BR>Email: info@sastasundar.com <BR>Website: http://www.sastasundarventures.com

View full answer

How has been the historical performance of Sastasundar Ven.?

02-Dec-2025

Sastasundar Ven.'s historical performance has shown significant fluctuations, with net sales decreasing to 1,110.95 Cr in Mar'25 from 1,375.71 Cr in Mar'24, resulting in a profit after tax of -122.74 Cr in Mar'25, down from 92.03 Cr in Mar'24. The company faced challenges in profitability and asset management during this period.

Answer:<BR>The historical performance of Sastasundar Ven. shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Sastasundar Ven. reported net sales of 1,110.95 Cr in Mar'25, a decrease from 1,375.71 Cr in Mar'24, but an increase from 1,039.81 Cr in Mar'23. The total operating income mirrored this trend, reaching 1,110.95 Cr in Mar'25, down from 1,375.71 Cr in the previous year. The total expenditure, excluding depreciation, was 1,166.98 Cr in Mar'25, down from 1,370.29 Cr in Mar'24. This resulted in an operating profit (PBDIT) of 3.81 Cr in Mar'25, a decline from 65.83 Cr in Mar'24. The profit before tax was -192.86 Cr in Mar'25, compared to 55.68 Cr in Mar'24, leading to a profit after tax of -122.74 Cr in Mar'25, down from 92.03 Cr in Mar'24. The consolidated net profit also fell to -91.17 Cr in Mar'25 from 8.88 Cr in Mar'24. On the balance sheet, total assets decreased to 963.16 Cr in Mar'25 from 1,149.19 Cr in Mar'24, while total liabilities also fell to 963.16 Cr in Mar'25 from 1,149.19 Cr in Mar'24. The cash flow from operating activities was 38 Cr in Mar'24, a recovery from -111 Cr in Mar'23, while the closing cash and cash equivalents increased to 33 Cr in Mar'24 from 31 Cr in Mar'23. Overall, the financial performance of Sastasundar Ven. reflects a challenging environment with notable volatility in profitability and asset management.

View full answer

Is Sastasundar Ven. technically bullish or bearish?

04-Dec-2025

As of December 3, 2025, Sastasundar Ven's technical trend has shifted to bullish, supported by positive daily moving averages, bullish weekly MACD and KST, and mildly bullish Bollinger Bands, indicating favorable momentum despite no signals from the RSI.

As of 3 December 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The daily moving averages are bullish, and the weekly MACD and KST are also bullish, indicating positive momentum. The Bollinger Bands on both weekly and monthly time frames are mildly bullish, suggesting potential upward movement. Despite the lack of signals from the RSI, the overall technical landscape remains favorable for Sastasundar Ven.

View full answer

Is Sastasundar Ven. overvalued or undervalued?

05-Dec-2025

As of December 4, 2025, Sastasundar Ven. is considered very expensive and overvalued, with a PE ratio of 14,101.14 and unfavorable comparisons to peers like Bajaj Finance and Life Insurance, suggesting that investors should exercise caution.

As of 4 December 2025, the valuation grade for Sastasundar Ven. has moved from risky to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios highlight this concern, with a staggering PE ratio of 14,101.14, an EV to EBIT of -13.69, and an EV to EBITDA of -14.80, all suggesting unsustainable valuations relative to its earnings and cash flows.<BR><BR>In comparison to peers, Sastasundar Ven. stands out unfavorably; for instance, Bajaj Finance has a PE of 34.9 and an EV to EBITDA of 19.63, while Life Insurance boasts a much more attractive PE of 10.85 and an EV to EBITDA of 8.92. These comparisons further reinforce the notion that Sastasundar Ven. is overvalued in the current market context. Despite a recent positive performance over the past month compared to the Sensex, the overall valuation metrics indicate that investors should approach this stock with caution.

View full answer

When is the next results date for Sastasundar Ventures Ltd?

30-Jan-2026

The next results date for Sastasundar Ventures Ltd is 06 February 2026.

The next results date for Sastasundar Ventures Ltd is scheduled for 06 February 2026.

View full answer

Are Sastasundar Ventures Ltd latest results good or bad?

07-Feb-2026

Sastasundar Ventures Ltd's latest results are concerning, with a net profit loss of ₹12.69 crores in Q2 FY26, a significant decline in profitability, and negative operating margins. Despite a 10.16% increase in net sales, ongoing operational inefficiencies and persistent losses suggest caution for investors.

Sastasundar Ventures Ltd's latest results indicate a challenging financial situation. In Q2 FY26, the company reported a consolidated net profit loss of ₹12.69 crores, marking a significant decline of 153.07% quarter-on-quarter and an 88.40% drop year-on-year. This is concerning, especially considering that the operating margin (excluding other income) fell to -7.50%, reflecting ongoing operational inefficiencies.<BR><BR>While net sales did show a modest increase of 10.16% year-on-year to ₹301.32 crores, this growth has not translated into profitability. The company has faced persistent losses, with negative operating profits recorded in five of the last seven quarters. Additionally, the return on equity (ROE) is notably low at just 3.66%, which is significantly below industry standards.<BR><BR>Overall, the results suggest that while there is some resilience in revenue growth, the inability to convert sales into sustainable profits, coupled with deteriorating margins and operational challenges, paints a negative picture for Sastasundar Ventures Ltd. Investors should approach the stock with caution given these red flags.

View full answer

Should I buy, sell or hold Sastasundar Ventures Ltd?

07-Feb-2026

Why is Sastasundar Ventures Ltd falling/rising?

13-Feb-2026

As of 13-Feb, Sastasundar Ventures Ltd's stock price is currently rising at 293.15, but it has declined over the past week and month. The stock shows mixed signals with falling investor participation and is trading above its 200-day moving average but below shorter-term averages, indicating a cautious outlook.

As of 13-Feb, Sastasundar Ventures Ltd's stock price is rising, currently at 293.15, reflecting a change of 2.1 (0.72%) upward. This increase is notable as the stock has outperformed its sector by 1.95% today. However, it is important to consider the broader context of the stock's performance. Over the past week, the stock has declined by 2.28%, and over the past month, it has fallen by 10.95%. <BR><BR>Despite the current rise, the stock has been experiencing falling investor participation, with a significant drop in delivery volume by 85.56% compared to the 5-day average. Additionally, while the stock is trading higher than its 200-day moving average, it remains below the 5-day, 20-day, 50-day, and 100-day moving averages, indicating mixed signals regarding its short-term momentum. <BR><BR>Overall, while the stock is currently rising, the recent trends in performance and investor participation suggest a cautious outlook moving forward.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

 
2

Flat results in Dec 25

3

With ROE of 0, it has a Very Expensive valuation with a 1.4 Price to Book Value

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 940 Cr (Micro Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

23

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

0.01%

stock-summary
Price to Book

1.36

Revenue and Profits:
Net Sales:
346 Cr
(Quarterly Results - Dec 2025)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.84%
0%
-1.84%
6 Months
5.72%
0%
5.72%
1 Year
6.21%
0%
6.21%
2 Years
-21.27%
0%
-21.27%
3 Years
14.53%
0%
14.53%
4 Years
-34.99%
0%
-34.99%
5 Years
125.5%
0%
125.5%

Latest dividend: 1 per share ex-dividend date: Jul-23-2012

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

09-Feb-2026 | Source : BSE

Please find the submission of Audio recording of the Earnings Conference call for Q3 FY26.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Feb-2026 | Source : BSE

Please find attached the copy of Newspaper publication of the Unaudited Financial Results for the quarter and nine months ended 31st December 2025

Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025

06-Feb-2026 | Source : BSE

Please find attached the Outcome of Board Meeting held today 6th February 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sastasundar Ventures Ltd has declared 10% dividend, ex-date: 23 Jul 12

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.32%
EBIT Growth (5y)
18.62%
Net Debt to Equity (avg)
0.01
Institutional Holding
4.32%
ROE (avg)
3.66%

Valuation key factors

Factor
Value
P/E Ratio
36
Industry P/E
23
Price to Book Value
1.37
EV to EBIT
-15.73
EV to EBITDA
-17.54
EV to Capital Employed
1.38
EV to Sales
0.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.67%
ROE (Latest)
0.01%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 5 FIIs (2.25%)

Promoter with highest holding

Banwari Lal Mittal (33.76%)

Highest Public shareholder

Lekh Raj Juneja (1.89%)

Individual Investors Holdings

12.72%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 22.91% vs -24.89% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 104.19% vs -3,492.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "345.74",
          "val2": "281.29",
          "chgp": "22.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.35",
          "val2": "-23.70",
          "chgp": "56.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.17",
          "val2": "0.05",
          "chgp": "240.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.23",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.13",
          "val2": "-26.94",
          "chgp": "104.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.99%",
          "val2": "-8.43%",
          "chgp": "5.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sastasundar Ven."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sastasundar Ven."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -19.66% vs 30.60% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -2,382.74% vs 105.88% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,089.53",
          "val2": "1,356.07",
          "chgp": "-19.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-77.45",
          "val2": "-14.16",
          "chgp": "-446.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.22",
          "val2": "1.07",
          "chgp": "-79.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "21.42",
          "val2": "35.68",
          "chgp": "-39.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-133.54",
          "val2": "5.85",
          "chgp": "-2,382.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7.64%",
          "val2": "-1.71%",
          "chgp": "-5.93%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
345.74
281.29
22.91%
Operating Profit (PBDIT) excl Other Income
-10.35
-23.70
56.33%
Interest
0.17
0.05
240.00%
Exceptional Items
0.00
-2.23
100.00%
Consolidate Net Profit
1.13
-26.94
104.19%
Operating Profit Margin (Excl OI)
-2.99%
-8.43%
5.44%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 22.91% vs -24.89% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 104.19% vs -3,492.00% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,089.53
1,356.07
-19.66%
Operating Profit (PBDIT) excl Other Income
-77.45
-14.16
-446.96%
Interest
0.22
1.07
-79.44%
Exceptional Items
21.42
35.68
-39.97%
Consolidate Net Profit
-133.54
5.85
-2,382.74%
Operating Profit Margin (Excl OI)
-7.64%
-1.71%
-5.93%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -19.66% vs 30.60% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -2,382.74% vs 105.88% in Mar 2024

stock-summaryCompany CV
About Sastasundar Ventures Ltd stock-summary
stock-summary
Sastasundar Ventures Ltd
Micro Cap
Healthcare Services
Sastasundar Ventures Limited was formerly established as ' Satyam Fiscal Services Private Limited' as a Private Limited Company on June 6, 1989. The Company changed the name from 'Satyam Fiscal Services Private Limited' to 'Microsec Financial Services Private Limited' on October 17, 2005. Subsequently, the status of the Company got converted into a Public Limited Company and the name of the Company was changed to 'Microsec Financial Services Limited' on October 21, 2005.
Company Coordinates stock-summary
Company Details
Azimganj House 2nd Floor, 7 Abanindra Nath Thakur Sarani Kolkata West Bengal : 700017
stock-summary
Tel: 91-33-22829330
stock-summary
info@sastasundar.com
Registrar Details
Link Intime India Pvt Ltd, 59 C , Chowringhee Road, 3rd Floor, Kolkata